Born in the Middle-East Region: Gabriel CHODICK, et al. Sackler Faculty of Medicine, Tel-Aviv University, Israel-Nosocomial transmission of varicella-zoster virus (VZV) is recognized as a significant cause of morbidity in health care workers as well as in high-risk patients. The current study aimed to investigate the presence of VZV antibodies among physicians and nurses, to assess the variables affecting it, and to compare it with previous international studies. Data were obtained by a questionnaire regarding sociodemographic and occupational characteristics and by determination of serum antibodies to varicella-zoster. The seroprevalence of varicella-zoster among the 335 study participants was 94.8% (95%CI: 91.9%-96.9%), with no significant difference between nurses (94%) and physicians (97%). Decreased risk for the virus was observed in workers who immigrated to Israel from the Asia or Africa (OR=0.15; 95% CI: 0.04-0.51). Reduced immunity among these workers remained significant in a multivariate model, which also included age, gender, years of education, number of siblings, and crowding at childhood. Our data suggest that in spite of the high immunity among Israeli physicians and nurses in general, the implementation of small-scale vaccination programs aimed at workers from warmer and tropical areas, should be seriously considered. (J Occup Health 2006; 48: 246-252) 
Varicella (chickenpox) is usually a mild disease in previously healthy children, but is typically more severe in neonates, adults, and immunocompromised patients, in whom it is more often associated with an acute course, complications and even mortality 1) . The proportion admitted to hospital per varicella case is high in children under two years of age (2% of cases), falls to approximately 0.50% in 2-to 18-year-olds then increases significantly throughout adult life to 6% in those over 65 yr 2) . The most common complications of varicella that result in hospitalization include secondary bacterial infection of skin lesions, pneumonitis, encephalitis and hepatitis 3) . Before the introduction of the active vaccine, of 3.9 million annual varicella cases in the United States, 10,000 were hospitalized and 90 to 100 died; of these, nearly half were adults 4, 5) . Similar hospitalization rates were reported in Canada 6) and Spain, where a total of 1.4 million cases of varicella were officially notified between 1995 and 2000 resulting in 48 deaths 7) . A live attenuated virus vaccine against varicella-zoster virus (VZV) was developed in Japan and has since been thoroughly tested for safety, efficacy and long-term effects. In March 1995 the vaccine was licensed in the U.S. only for use in healthy individuals. A clinical case control study assessed the vaccine effectiveness as 85%, with 97% protection against moderately-severe and severe cases 8) . Nosocomial transmission of VZV is recognized as a significant cause of morbidity in health care workers (HCWs) as well as in high risk patients 9) . Hence, active immunization with VZV vaccine is suggested to protect susceptible HCWs from serious disease and to prevent subsequent transmission to their patients 10, 11) . However, there is no general agreement regarding the vaccination policy against varicella of HCWs, and how to manage exposed hospital staff after an exposure. The drawbacks of mass immunization campaigns against the infection are the high natural immunity to VZV, incomplete compliance with vaccination, the cost of the vaccine and its adverse effects. Determining varicella immunity among HCWs has substantial importance in determining a judicious preventive policy to eliminate infections among workers and patients.
In Israel, a serosurvey on the immunity to VZV showed that 98% of young adults (aged 18 yr) had natural antibodies against VZV 12) . However, our recently published data 13) on 573 adults showed lower seroprevalence rate among workers exposed to children (HCWs and day care centre workers) compared to controls. The current study aimed to investigate the presence of VZV antibodies among physicians and nurses, to assess the variables affecting it, and to compare it with international data. This should allow better targeting of susceptible workers.
Methods

Study population
As described in our previous study 14) a questionnaire was completed by and serum specimens were collected from health care employees in Israel. The study population was comprised of two subgroups: HCWs of a tertiary-care center and of community clinics.
Hospital workers: we randomly sampled sera of 279 employees, 64 physicians and 115 nurses, of Israel's largest children's hospital and a large medical center, located on the same campus.
Community clinic workers: We selected a random cluster sample of 42 clinics in central Israel, belonging to the largest national health-maintenance organization, with a membership of 3.5 million people countrywide. Six clinics were excluded since they had less than four staff members; one clinic was unavailable and one refused to participate. Eventually, the community clinics population comprised 156 employees, 73 community nurses and 83 physicians. Thus, the total study sample was comprised of 188 nurses and 147 physicians.
Questionnaire Assays: Sample sera were blindly analyzed for IgG to VZV with a commercial ELISA kit (PANBIO, Columbia, MD) using microwells coated with VZV antigens. Cut- 15) .
Statistical analysis
The chi square test was used to analyze differences among proportions when categorical variables were applied. Confidence intervals (CI) were calculated according to formula presented by Newcombe et al. 16 ) . Since we identified no VZV-negative male worker, we calculated the risk assuming one VZV-negative case. The Mantel-Haenszel test for trends was used to evaluate statistical significance in univariate analyses. The Odds Ratio (OR) and 95% confidence intervals of immunity to VZV were derived from stepwise unconditional multiple logistic regression models, fitted by the method of maximum likelihood. The analysis was conducted by means of SPSS11.0 for Windows (SPSS, Inc., Chicago, IL).
Results
Both nurses and physicians had a similar mean age (42.5 yr; SD= ± 12.5 and 41.26 yr; SD= ± 11.5, respectively). Of the 188 sampled nurses, only two participants were males (1.1%) compared to 48.3% among physicians (Table 1) .
The seroprevalence of VZV antibodies among the 335 study participants was 94.8% (95%CI: 91.9%-96.9%). Men presented a higher risk for VZV immunity (OR=5.00; 95%CI:0.65-38.18). No significant differences in immunity against VZV were observed among age groups, professions (physician and nurses), occupational affiliation, or ethnicity (Table 2) . Having more than 15 yr of education showed an increased risk (OR=3.41; 95% C.I: 0.83-13.98), while a significantly (p<0.05) decreased risk was observed for participants who were born in Asian/African countries other than Israel (OR=0.15; 95% CI: 0.04-0.64). Asian or African origin remained significantly (p=0.05) associated with lower immunity to VZV (OR=0.20; 95%CI:0.04-1.00) in a multivariate model including employee's age, gender, years of education, number of siblings, and crowding at childhood. Seroprevalence levels of the current study participants and previously published studies from the USA, Japan, and Saudi Arabia, are depicted in Fig. 1 .
Discussion
The current study results suggest that the majority (95%) of Israeli nurses and physicians have a positive varicella serology. We could not demonstrate a significant correlation between age and seropositivity, as shown by another seroepidmiologic study 17) , since most workers were over 30 yr, with already very high immunity rates. We also did not find any correlation with number of siblings or familial crowding, which was suggested by another investigation 18) . Our results are consistent with a previous study on 241 employees at the Milwaukee Medical Complex 19) , which found a 98.2% immunity among nurses. A similar study among 154 house officers beginning their residency at a universityaffiliated teaching hospital showed that 96.2% (95% CI:93.2%-99.2%) had protective titers to varicella 20) . In contrast, a previous study on varicella in healthcare settings 21) showed significant seroprevalence differences among various health occupations, as student nurses present the highest seropositivity rates. It also conflicts with a relatively low immunity rate (79%) demonstrated among 42 hospital workers in the southeastern US 22) . Our study has several limitations. First, participants were not asked for past varicella infection history, since the blood samples were originally collected for hepatitis A serology testing. However, the unreliability of such questions as an indicator of immunity has been commented on by a number of studies [23] [24] [25] . The relatively small number of non-immune subjects resulted in a relatively low study power (e.g. the power of the continuity-corrected chi-square test to detect differences between physicians and nurses in minimal significance of p<0.1 was only 23.76%). It also did not permit elaborated interaction analysis. The commercially available serological assays, were previously proven problematic with sub-optimal validity in comparison to fluorescent antibody to membrane antigen (FAMA) and ELISA, which was used in the current study 15) . It may therefore leave room to doubt whether the few individuals with negative results are in fact unlikely to be protected from serious chickenpox. Hence, the suggested strategy for seronegative workers' immunization is the checking of titers by more accurate tests such as latex agglutination (LA) or FAMA 26) . Participants who immigrated to Israel from Asia/Africa (Middle-Easterner countries) had a significantly lower immunity compared to other workers. This may be Fig. 1 . Seroprevalence rates of VZV among healthcare workers according to place of birth and age. a. Age <35, adopted from ref 19) . b. Adopted from ref 34) . c. Adopted from ref 36) .
attributable to the fact that in temperate regions, most individuals are infected during early childhood while in tropical regions VZV affects both adults and children 27) . The susceptibility among HCWs in temperate regions is therefore lower, ranging from 1% to 7% (median 3%) [28] [29] [30] [31] . High immunity rates (≥97%) were calculated among large samples of HCWs in Ohio 32) , California 33) , Japan 34) , and Belgium 29, 35) . In contrast, investigation of a cohort of 1,058 newly recruited employees in a tertiary-care center located in Riyadh, Saudi Arabia 36) , found an immunity rate of only 84% to VZV. Similarly with our results (Fig. 1) , the seropositivity rate among adults from European countries (91%) was higher compared to Middle Easterners (87%) and substantially higher compared to workers from Asian tropical regions (77%). Furthermore, due to geopolitical circumstances, the vast majority of Israelis in the labor force who were born in Middle-Eastern countries, immigrated to Israel between 1948 and 1967, namely, during childhood or young adulthood. This includes the current study in which all four susceptible persons among the 26 workers born in Middle Eastern countries, immigrated to Israel more than 40 yr ago. Because origin-associated differences in the VZV immunity probably remained throughout adulthood, expatriate personnel from Middle-Eastern regions are at an increased risk of infection, even if they had immigrated as children many years ago. This is of special importance for the growing numbers of foreign workers who arrive in Israel from tropical regions (e.g. Thailand and the Phillipines) to work at nursing homes and other medical facilities. Since the susceptiblity among such workers may reach 25% 37) they are exposed to potentially serious sequela and possible transmission to other workers and vulnerable patients.
The licensure of varicella vaccine in Israel provides an opportunity to prevent this previously pervasive childhood infection. It could be desirable to identify and immunize only those workers without evidence of immunity. However, testing for varicella immunity requires a blood test, follow-up and repeated visits for the administration of vaccine to seronegative workers. This approach involves costs to the health care system as well as loss of labor time. In addition, the outbreak of varicella at a day-care center was reported despite vaccination, raising questions on the practical effectiveness of the vaccine in its current sequeaule 38) . Thus, the decision upon an appropriate algorithm for the prevention policy of varicella in HCWs requires a careful cost-effectiveness analysis. The overall susceptibility rate of 5% among our HCWs may support an evidence-based analysis to determine the optimal policy of the initial and annual management of HCWs and the management of employees exposed to varicella. Such policy planning should also consider changes in the epidemiology of the disease in recent years as the result of a steady increase in the coverage of varicella vaccine among young children since the licensure of the Varilrix vaccine in Israel in 1999. Although the vaccine is not given routinely by the public health system-primarily for economic reasonsit has been available for individual purchasing through the nation's four HMOs. A recent study at one HMO showed that 16.3% of 161,557 children born between 1998 and 2002 had already received the vaccine by their parents' initiative 39) . Increased compliance with vaccination at early ages may reduce the attack rates of varicella and the attractiveness of the varicella vaccination campaign among HCWs.
The origin-specific susceptibility rates found in the present study may not be generalized to all other hospitals in different georgaphic locations. Further research is needed to establish these and previous observations and to determine the exact mechanisms in which the place of birth and the age at immigration affect the susceptibility to VZV in adulthood. It is concluded that although our previous cost-effectiveness study 40) showed that vaccination of health workers is expensive compared with accepted interventions for other medical conditions, and thus not recommended as routine policy, the results of the current study suggest that implementation of smallscale vaccination programs aimed at workers from warmer and tropical areas where higher susceptibility was found, should seriously be considered. 
